Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma

BACKGROUND: The vascular endothelial growth factor receptor-2 (VEGFR-2) plays an important role in melanoma development and progression. Peptide vaccines have shown great potential in cancer immunotherapy by targeting VEGFR-2 as a tumor-associated antigen and boosting the immune response against bot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahedipour, Fatemeh, Zamani, Parvin, Mashreghi, Mohammad, Astaneh, Mojgan, Sankian, Mojtaba, Amiri, Atefeh, Jamialahmadi, Khadijeh, Jaafari, Mahmoud Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264216/
https://www.ncbi.nlm.nih.gov/pubmed/37333490
http://dx.doi.org/10.1186/s12645-023-00213-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264216/
https://www.ncbi.nlm.nih.gov/pubmed/37333490
http://dx.doi.org/10.1186/s12645-023-00213-7

Ejemplares similares